Kite Pharma, Tel Aviv Sourasky Medical Center deal
WIR Staff
February 16, 2015 8:00 AM UTC
Kite and the center expanded a deal to develop chimeric antigen receptor (CAR) T cell therapies to treat various tumor types. The parties could not be reached for details. ...